In the face of senators' criticism, Moderna CEO Stéphane Bancel did not agree to lower the commercial cost of the company's COVID-19 vaccine in a hearing Wednesday on the vaccine's price.
An appeals court has ruled resoundingly in favor of an Ojai pharmacy and 21 other independent drugstores that claim massive PBM Optum Rx underpays medication reimbursements in an effort to push them out of existence.
Sanofi agreed to buy Provention Bio Inc. in a $2.9 billion deal intended to bolster the French drugmaker's portfolio of diabetes medicines with a new therapy recently approved in the U.S.
Novo Nordisk said this week it will slash the list prices of several of its popular pre-filled insulin pens and vials by up to 75%, becoming the latest drugmaker to reduce the cost of the critical medicine for diabetes patients.
Despite being exposed to the tune of $8 to $10 million in the collapse of Silicon Valley Bank, Mark Cuban considers himself relatively lucky. Speaking on Twitter Spaces this weekend, Cuban laid bare what he believes the priorities should be for impacted parties: supporting startups to sign off their payroll and invoices to vendors, so their creditors in turn can continue to operate.